|
Heart Failure Adherence and Retention Trial (HART) Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Heart Failure Adherence and Retention Trial (HART) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Heart Failure Adherence and Retention Trial (HART) Clinical research trials and Heart Failure Adherence and Retention Trial (HART) healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Heart Failure Adherence and Retention Trial (HART). Heart Failure Adherence and Retention Trial (HART) Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Heart Failure Adherence and Retention Trial (HART) clinical trial. Subjects frequently obtain the most expert healthcare possible for their Heart Failure Adherence and Retention Trial (HART) condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > Heart Failure Adherence and Retention Trial (HART)  Heart Failure Adherence and Retention Trial (HART)
Heart Failure Adherence and Retention Trial (HART)
For Condition: Heart Failure, Congestive,Cardiovascular Diseases,Heart Diseases,Heart Failure
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To test whether a self-management (SM) intervention, compared to usual care, will reduce the risk for adverse clinical outcome in patients with mild to moderate heart failure.
Details: BACKGROUND: Heart failure is a major disabling disease for American adults, affecting an estimated 4.9 million individuals. Because heart failure is a progressive chronic condition, characterized by disabling symptoms which limit independence and result in multiple hospitalizations and referral to long-term care it is associated with enormous health care expenditures. The emergence of heart failure as a major public health problem appears related to the unintended result of both the aging of the population and success in reducing mortality from cardiovascular disease. Non-adherence to medications is a key problem in the treatment of heart failure with adherence rates ranging from 20 to 90 percent. There is a clear need, therefore, to develop interventions that improve adherence in patients with heart failure. DESIGN NARRATIVE: This is a single-site, partially blinded, randomized clinical trial of 900 patients with systolic or diastolic dysfunction and NYHA functional class II, or III. Patients will be recruited over a period of two years using seven hospitals. Patients will be randomized to self-management intervention or an attention control and will meet 18 times for 1.5 hours over one year. These sessions will teach patients how to use five basic self-management skills (self-monitoring, environmental restructuring, social support, cognitive restructuring, and the relaxation response) to help them build self-efficacy and maintain it after the treatment has been discontinued. The attention control intervention will consist of a didactic lecture series about medical topics and heart failure. Treatment effects will be evaluated using the primary outcome of hospitalization for heart failure or death, and the secondary outcomes of progression of heart failure, quality of life, and health care costs. Potential mediators of effectiveness include improved adherence and improved psychosocial function.
Eligibility:
Study Type: Interventional, Treatment, Randomized
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
LyndaPowell, , Rush-Presbyterian-St. Lukes Medical Center
Rush-Presbyterian-St. Lukes Medical Center *Recruiting*
Chicago, Illinois, 60612
United States
Recruiting Dr. H. Powell 312-942-2013
Additional Information:
Study ID Numbers: 137;
Study Start Date: June 2001
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00018005
Other Heart Failure, Congestive Studies:
1. Fat Reduction Intervention Trial in African-Americans
2. Genetic Epidemiology of Change in CVD Risk Factors
3. Black Pooling Project
4. Anxiety and Vagal Control of the Heart in Coronary Disease
5. Hypertension in Black Americans: A Life Course Approach
Related Studies:
Other Heart Failure, Congestive Clinical Trials
Other Illinois Clinical Trials
Other Chicago Clinical Trials
Heart Failure Adherence and Retention Trial (HART)
|
|
|
|
|
|
|
|
